TY - JOUR
T1 - Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
AU - Kumar, Pardeep
AU - Kuhlmann, F. Matthew
AU - Chakraborty, Subhra
AU - Bourgeois, A. Louis
AU - Foulke-Abel, Jennifer
AU - Tumala, Brunda
AU - Vickers, Tim J.
AU - Sack, David A.
AU - DeNearing, Barbara
AU - Harro, Clayton D.
AU - Wright, W. Shea
AU - Gildersleeve, Jeffrey C.
AU - Ciorba, Matthew A.
AU - Santhanam, Srikanth
AU - Porter, Chad K.
AU - Gutierrez, Ramiro L.
AU - Prouty, Michael G.
AU - Riddle, Mark S.
AU - Polino, Alexander
AU - Sheikh, Alaullah
AU - Donowitz, Mark
AU - Fleckenstein, James M.
N1 - Funding Information:
The authors wish to thank Margaret A. Olsen (Center for Administrative Data Research at Washington University) for her expert help and advice in analysis of clinical metadata associated with these studies, and David A. Rasko (University of Maryland) and Elizabeth Cebelinski (Minnesota Department of Health) for sending additional ETEC isolates. This work was supported by funding from The Enteric Vaccine Initiative of PATH; The Department of Veterans Affairs (VA) (5I01BX001469-05); NIH grants R01AI89894, R01AI126887, K23 AI130389-01, and P01AI125181; Clinical and Translational Sciences Award UL1TR000448 from the NIH; the Digestive Diseases Research Core Center at Washington University School of Medicine; and grant P30 DK52574 from the National Institute of Diabetes and Digestive and Kidney Diseases. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the PATH, the VA, the National Institute of Allergy and Infectious Diseases (NIAID), the NIH, the Department of the Navy, the Department of Defense, or the US Government. Some of the authors are military service members (RLG, MGP, MSR) or employees of the US government (CKP). This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that “Copyright protection under this title is not available for any work of the United States government.” Title 17 U.S.C. §101 defines a US government work as a work prepared by a military service member or employee of the US government as part of that person’s official duties.
Publisher Copyright:
© 2018 American Society for Clinical Investigation. All rights reserved.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Enterotoxigenic Escherichia coli (ETEC) infections are highly prevalent in developing countries, where clinical presentations range from asymptomatic colonization to severe cholera-like illness. The molecular basis for these varied presentations, which may involve strain-specific virulence features as well as host factors, has not been elucidated. We demonstrate that, when challenged with ETEC strain H10407, originally isolated from a case of cholera-like illness, blood group A human volunteers developed severe diarrhea more frequently than individuals from other blood groups. Interestingly, a diverse population of ETEC strains, including H10407, secrete the EtpA adhesin molecule. As many bacterial adhesins also agglutinate red blood cells, we combined the use of glycan arrays, biolayer inferometry, and noncanonical amino acid labeling with hemagglutination studies to demonstrate that EtpA is a dominant ETEC blood group A-specific lectin/ hemagglutinin. Importantly, we have also shown that EtpA interacts specifically with glycans expressed on intestinal epithelial cells from blood group A individuals and that EtpA-mediated bacterial-host interactions accelerate bacterial adhesion and effective delivery of both the heat-labile and heat-stable toxins of ETEC. Collectively, these data provide additional insight into the complex molecular basis of severe ETEC diarrheal illness that may inform rational design of vaccines to protect those at highest risk.
AB - Enterotoxigenic Escherichia coli (ETEC) infections are highly prevalent in developing countries, where clinical presentations range from asymptomatic colonization to severe cholera-like illness. The molecular basis for these varied presentations, which may involve strain-specific virulence features as well as host factors, has not been elucidated. We demonstrate that, when challenged with ETEC strain H10407, originally isolated from a case of cholera-like illness, blood group A human volunteers developed severe diarrhea more frequently than individuals from other blood groups. Interestingly, a diverse population of ETEC strains, including H10407, secrete the EtpA adhesin molecule. As many bacterial adhesins also agglutinate red blood cells, we combined the use of glycan arrays, biolayer inferometry, and noncanonical amino acid labeling with hemagglutination studies to demonstrate that EtpA is a dominant ETEC blood group A-specific lectin/ hemagglutinin. Importantly, we have also shown that EtpA interacts specifically with glycans expressed on intestinal epithelial cells from blood group A individuals and that EtpA-mediated bacterial-host interactions accelerate bacterial adhesion and effective delivery of both the heat-labile and heat-stable toxins of ETEC. Collectively, these data provide additional insight into the complex molecular basis of severe ETEC diarrheal illness that may inform rational design of vaccines to protect those at highest risk.
UR - http://www.scopus.com/inward/record.url?scp=85051266449&partnerID=8YFLogxK
U2 - 10.1172/JCI97659
DO - 10.1172/JCI97659
M3 - Article
C2 - 29771685
AN - SCOPUS:85051266449
SN - 0021-9738
VL - 128
SP - 3298
EP - 3311
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
ER -